Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Radiopharm Theranostics Limited ( (AU:RAD) ) has issued an announcement.
Radiopharm Theranostics Limited has issued 133,333,333 ordinary fully paid shares without disclosure under the Corporations Act. The company has complied with relevant provisions of the Corporations Act, indicating transparency and adherence to legal requirements, which could enhance stakeholder trust and support its strategic objectives.
More about Radiopharm Theranostics Limited
Radiopharm Theranostics Limited operates in the medical technology industry, focusing on the development of radiopharmaceutical products for diagnostic and therapeutic purposes.
YTD Price Performance: 16.67%
Average Trading Volume: 9,715,595
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$61.62M
See more data about RAD stock on TipRanks’ Stock Analysis page.
